EBS 2.98 NARCAN® — comprises contributions from NARCAN® Nasal Spray
Other Commercial Products - comprises contributions from Vaxchora® and Vivotif®, which we sold to Bavarian Nordic as part of our travel health business in May 2023
Anthrax MCM — comprises potential contributions from CYFENDUS®, previously known as AV7909, BioThrax®, Anthrasil® and Raxibacumab
Smallpox MCM — comprises potential contributions from ACAM2000®, VIGIV and TEMBEXA®
Other Products — comprises potential contributions from BAT®, RSDL® and Trobigard®
Bioservices — comprises service and lease revenues from the Bioservices business
